SCHEMBL24466765

SCHEMBL24466765

c1ccc(-c2nc3cc(-c4cc(-c5ccc6sc(-c7ccccc7)nc6c5)cc(-c5cccc6c5-c5ccccc5C65c6ccccc6Oc6ccccc65)c4)ccc3s2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.38
NFKB1 P19838 9/20 0.36
RAB9A P51151 9/20 0.36
NFKB2 Q00653 9/20 0.36
RELA Q04206 9/20 0.36
NPC1 O15118 7/20 0.36
HPGD P15428 4/20 0.36
STAT1 P42224 1/20 0.36
MAPT P10636 7/20 0.35
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
GAA P10253 3/20 0.35
POLB P06746 2/20 0.35
GFER P55789 1/20 0.35
SMN1; SMN2 Q16637 8/20 0.35
PKM P14618 4/20 0.35
GLA P06280 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24466699 0.88 RAB9A (0.42) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24466764 0.86 RAB9A (0.41) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24466698 0.86 RAB9A (0.41) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24466762 0.86 RAB9A (0.41) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24476783 0.84 APP (0.43) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24466711 0.81 RAB9A (0.46) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24476788 0.81 RAB9A (0.43) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24476787 0.81 RAB9A (0.43) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24476883 0.81 RAB9A (0.45) KDM4ENFKB1RAB9ANFKB2RELA
SCHEMBL24466771 0.80 TDP2 (0.46) KDM4ENFKB1RAB9ANFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173333-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2022-06-02 US disclosed
EP-4006025-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173333-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF KCNH1, OCIAD2, ETFB KDM4E 2755/4885NFKB1 3726/4885RAB9A 1714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.